Pediatric Hemophilia A:
Early Factor VIII Use and
Lifelong Treatment Planning
A CME/CNE Activity featured on Medscape
Hematology/Oncology
November 28, 2025 – May 28, 2026

Expert Insights: Addressing Critical Questions
in the Evolving Management of Advanced Ovarian Cancer
A CME/CNE Activity, featured on Medscape
September 1, 2018

Expert Insights: Addressing Critical Questions
in the Evolving Management of
Advanced Ovarian Cancer
A CME/CNE Ancillary Event Convened
During the American Society of
Clinical Oncology (ASCO) Annual Meeting
June 2, 2018
Chicago, IL

Advances in the Management of Opioid-Induced
Constipation in Cancer-Related Pain
Medscape Posting of the CME/CNE Symposium
Presented at the 4^th Annual Cancer Research
Pain Consortium Conference
April 14, 2018
New Orleans, LA

Advances in the Management of Opioid-Induced
Constipation in Cancer-Related Pain
A CME/CNE Symposium Presented at the
4^th Annual Cancer Research Pain Consortium Conference
April 14, 2018
New Orleans, LA

Evaluating the Role of Biosimilars in Oncology:
Implications for Clinical Pharmacists
An Official Commercially Supported CPE Symposium
Held in Conjunction With
The Hematology/Oncology Pharmacy Association’s
14^th Annual Conference
March 24, 2018
Colorado Convention Center
Denver, CO

Evaluating the Role of Biosimilars in Oncology:
Implications for Clinical Pharmacists
A CE Midday Symposium Conducted at the
52^nd ASHP Midyear Clinical Meeting and Exhibition
Wednesday, December 6, 2017
Orange County Convention Center
Orlando, FL

Next-Gen EGFR TKIs for NSCLC:
Novel Strategies and Clinical Pharmacy Implications
A CME/CNE Activity, featured on Medscape
March 2, 2016

Next-Gen EGFR TKIs for NSCLC:
Novel Strategies and Clinical Pharmacy Implications
A Symposium Conducted at the
50^th ASHP Midyear Clinical Meeting and Exhibition
Monday, December 7, 2015
Ernest N. Morial Convention Center
New Orleans, LA

Identification and Innovation of
Novel EGFR TKIs for NSCLC
A CME/CNE Activity, featured on Medscape
July 15, 2015

Identification and Innovation of
Novel EGFR TKIs for NSCLC
A CME/CNE Ancillary Event Convened During
The ASCO Annual Meeting
Saturday, May 30, 2015
Hilton Chicago
Chicago, IL

Ovarian Cancer: Evolution and Evidence
for Emerging Strategies
A CME/CNE Activity, featured on Medscape
Saturday, March 28, 2015

Ovarian Cancer: Evolution and Evidence for
Emerging Strategies An independent CME Satellite Symposium During
The Annual Meeting on Women’s Cancer^®
Saturday, March 28, 2015
Hilton Chicago
Chicago, IL

Ovarian Cancer – Evolution & Evidence
for Emerging Strategies.
A CME/CNE Symposium to be held during
the Society of Gynecologic Oncology
(SGO) 46^th Annual Meeting on Women’s Cancer
March 28, 2015
Hilton Chicago

PARP Inhibition for BRCA
1/2 Mutation - Associated and
Triple Negative BC – Advances
in Risk Reduction & Treatment
A CME/CNE Activity, featured on Medscape
March 15, 2015

PARP Inhibition for BRCA
1/2 Mutation - Associated and
Triple Negative BC – Advances
in Risk Reduction & Treatment

Genomic Strategies for Screening,
Prevention and Emerging Clinical
Interventions for Ovarian Cancer

BRCA Mutations: Strategies for Reducing Risk
& Emerging Therapies
A CME/CNE Symposium Convened During the
36^th San Antonio Breast Cancer Symposium
December 13, 2013
San Antonio Marriott Rivercenter Hotel

Advances in Cancer Research & Practice
2012 Update on Current Therapies and
Issues in Oncology Nursing

Targeting Histology & Oncogenic
Drivers of NSCLC: Guidelines & Evidence
An Interactive Tumor Board

Advances in Cancer Research & Practice
Update on Current Therapies
and Issues in Oncology Nursing
A CNE-accredited Cancer Nursing Conference

A CME/CNE-accredited Satellite Symposium
Presented at the
International Society of Gastrointestinal Oncology (ISGIO)
8^th Annual Gastrointestinal Oncology Conference
Optimizing Clinical Benefits With
Targeted Therapies in GIST

The Eighth Annual Meeting
of the International Society
of Gastrointestinal Oncology

Lung Cancer Summit
Recent Advances in Lung
Cancer Treatment: Presentations,
Case Studies and Discussions
from Leading Medical & Surgical
Experts from NCCN/NCI-designated
Cancer Centers

Advances in Cancer Research
and Practice:
2010 CNE Oncology Nursing Conference

International Society of
Gastrointestinal Oncology’s
7^th Annual Scientific Meeting,
The 2010 Gastrointestinal
Oncology Conference

Lung Cancer Summit
2010/2011

Optimal Sequencing & Risk
Stratification of Patients With
Advanced GIST CME Satellite
Symposium Presented at the
7^th Annual ISGIO Conference

Advances in Cancer Research
and Practice: 2009 CNE
Oncology Nursing Conference

Expanding Role of Targeted
Therapy of GIST: A CME
Satellite Symposium
Convened During the 6^th
Annual Meeting of the
International Society of
Gastrointestinal Oncology

Turning Point: AI Technology
Assessment in the Era of
Evidence-based Medicine:
A CME/CNE Accredited Didactic
and Case-based Educational Event

Optimizing Patient Care
in the Era of Novel Therapies
for Renal Cell Carcinoma:
A CNE Accredited Satellite
Symposium Presented at the
Oncology Nursing Society

Advances in Cancer Research
and Practice: 2008 CNE
Oncology Nursing Conference

Advances and Evolving Role
of Targeted Therapy in GIST:
Convened During the 4^th Annual
Meeting of the International Society
of Gastrointestinal Oncology

Examining the Controversies
in the Expanding Role of AIs —
Case-based Learning
Presented by the Experts:
A CME Satellite Symposium Convened
at the 31st Annual San Antonio
Breast Cancer Symposium

Advances in Cancer Research
and Practice: 2007 CNE
Oncology Nursing Conference

Optimizing Survival Outcomes
With Aromatase Inhibition in the
Era of Evidence-based Medicine:
A CME Satellite Symposium
Convened During the 30^th Annual
San Antonio Breast Cancer Symposium

Advances in Cancer Research
and Practice:
2006 CNE Oncology Nursing Conference

Advances and Evolving Role of
Targeted Therapy in GIST:
Convened During the 4^th Annual
Meeting of the International
Society of Gastrointestinal Oncology

Changing Landscapes of Adjuvant
Endocrine Therapies:
A CME Satellite Symposium Held
During the 29^th Annual
San AntonioBreast Cancer Symposium

Targeting Receptors:
Evolution and Revolution in
Breast Cancer Therapy:
A CME Satellite Symposium in
Conjunction with the ASCO
42^nd Annual Meeting

Pathways to Progress:
Breakthroughs in
Targeted Cancer Therapy:
A CME Satellite Symposium
Presented in Conjunction
with the ASCO 42^nd Annual Meeting

Advances in Targeted Molecular
Therapies for RCC:
A CME Satellite Symposium Presented
at the National Kidney Foundation
2006 Spring Clinical Meetings

Advances in Cancer Research
and Practice:
2005 CNE Oncology Nursing Conference

Managing Menopause After
Breast Cancer:
A CME Satellite Symposium
Convened During the 28th
Annual San Antonio Breast
Cancer Symposium

Optimal Use of Aromatase Inhibitors —
Upfront vs Switching Strategies:
A CME Satellite Symposium Convened
During the 28^th Annual
San Antonio Breast Cancer Symposium

Evolving Strategies
in Prostate Cancer

Advances and Evolving Role
of Novel Targeted Therapy
in GIST:
A CME Satellite Symposium
Convened During the 2005
Annual Meeting of the
International Society of
Gastrointestinal Oncology

Breast Oncology Update
From Orlando:
Review of Information & Insights

From Principles to Practice:
Role of Anthracyclines and Taxanes
for Early Breast Cancer:
A CME Satellite Symposium Convened
During the 22^nd Annual Meeting of
the Miami Breast Cancer Conference

Advances in Cancer Research
and Practice:
2004 CNE Oncology Nursing Conference

From Principles to
Practice — Advances
in Dose Dense Strategies &
Anthracycline Treatment:
A CME Satellite Symposium
Convened at the 27^th Annual
San Antonio Breast
Cancer Symposium

Breaking the Five-Year SERM Barrier —
Perspectives on Clinical Applications of
New Data and Strategies in the Adjuvant
Setting for Early Breast Cancer:
The Official Satellite Symposium
Convened at the 27^th Annual San Antonio
Breast Cancer Symposium